{"doi":"10.3390/ijms23116001","title":"MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance","abstract":"<jats:p>Microphthalmia-associated transcription factor (MITF) is an important regulator of melanogenesis and melanocyte development. Although it has been studied extensively in cutaneous melanoma, the role of MITF in uveal melanoma (UM) has not been explored in much detail. We review the literature about the role of MITF in normal melanocytes, in cutaneous melanoma, and in UM. In normal melanocytes, MITF regulates melanocyte development, melanin synthesis, and melanocyte survival. The expression profile and the behaviour of MITF-expressing cells suggest that MITF promotes local proliferation and inhibits invasion, inflammation, and epithelial-to-mesenchymal (EMT) transition. Loss of MITF expression leads to increased invasion and inflammation and is more prevalent in malignant cells. Cutaneous melanoma cells switch between MITF-high and MITF-low states in different phases of tumour development. In UM, MITF loss is associated with loss of BAP1 protein expression, which is a marker of poor prognosis. These data indicate a dual role for MITF in benign and malignant melanocytic cells.</jats:p>","journal":"International Journal of Molecular Sciences","year":2022,"id":592931,"datarank":2.35597669517591,"base_score":4.477336814478207,"endowment":4.477336814478207,"self_citation_contribution":0.6716005221717312,"citation_network_contribution":1.6843761730041784,"self_endowment_contribution":0.6716005221717312,"citer_contribution":1.6843761730041784,"corpus_percentile":null,"corpus_rank":null,"citation_count":87,"citer_count":85,"citers_with_citation_signal":68,"citers_with_endowment":68,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1517376,"name":"Laurien E. Houtzagers","orcid":"0000-0003-1646-3723","position":1,"is_corresponding":false},{"id":1517377,"name":"Thomas Strub","orcid":"0000-0001-6252-0181","position":2,"is_corresponding":false},{"id":1517378,"name":"Imène Krossa","orcid":null,"position":3,"is_corresponding":false},{"id":478475,"name":"Martine J. Jager","orcid":"0000-0003-2261-3820","position":4,"is_corresponding":false},{"id":1214480,"name":"Maria Chiara Gelmi","orcid":"0000-0002-9099-009X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance","abstract":"<jats:p>Microphthalmia-associated transcription factor (MITF) is an important regulator of melanogenesis and melanocyte development. Although it has been studied extensively in cutaneous melanoma, the role of MITF in uveal melanoma (UM) has not been explored in much detail. We review the literature about the role of MITF in normal melanocytes, in cutaneous melanoma, and in UM. In normal melanocytes, MITF regulates melanocyte development, melanin synthesis, and melanocyte survival. The expression profile and the behaviour of MITF-expressing cells suggest that MITF promotes local proliferation and inhibits invasion, inflammation, and epithelial-to-mesenchymal (EMT) transition. Loss of MITF expression leads to increased invasion and inflammation and is more prevalent in malignant cells. Cutaneous melanoma cells switch between MITF-high and MITF-low states in different phases of tumour development. In UM, MITF loss is associated with loss of BAP1 protein expression, which is a marker of poor prognosis. These data indicate a dual role for MITF in benign and malignant melanocytic cells.</jats:p>","is_dataset_classified":null,"base_score":4.477336814478207,"endowment":4.477336814478207,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"35682684","pmcid":"PMC9181002","openalex_id":"https://openalex.org/W4281715147","authors":[],"funders":[{"funder_name":"Leiden University Fund","grant_id":"2021-1","title":null},{"funder_name":"the Bontius Foundation","grant_id":"","title":null}],"total_grants":2,"fwci":8.4958,"citation_percentile":0.9893817,"influential_citations":0,"citation_trend":[{"year":2022,"count":2},{"year":2023,"count":23},{"year":2024,"count":26},{"year":2025,"count":28},{"year":2026,"count":8}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.mdpi.com/1422-0067/23/11/6001/pdf?version=1653637851","host_type":"journal"},{"url":"https://www.mdpi.com/1422-0067/23/11/6001/pdf?version=1653637851","host_type":"publisher"},{"url":"https://www.mdpi.com/1422-0067/23/11/6001/pdf","host_type":"publisher"},{"url":"https://doi.org/10.3390/ijms23116001","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/35682684","host_type":"repository"},{"url":"http://hdl.handle.net/1887/3485615","host_type":"repository"},{"url":"https://dx.doi.org/10.3390/ijms23116001","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9181002","host_type":"repository"},{"url":"https://hdl.handle.net/1887/3485615","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC9181002","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC9181002?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["melanin and skin pigmentation","Ocular Oncology and Treatments","Retinal Development and Disorders"],"mesh_terms":["Melanoma, Cutaneous Malignant","Cutaneous Malignant Melanoma","Uveal Melanoma","Humans","Inflammation","Melanocytes","Melanoma","Skin Neoplasms","Uveal Neoplasms","Microphthalmia-Associated Transcription Factor"],"keywords":["Microphthalmia-associated transcription factor","Melanoma","Melanocyte","Cancer research","Melanin","Inflammation","Biology","Epidermis (zoology)","IRF4","Cell biology","Transcription factor","Immunology","Anatomy","Genetics","Eye","Oncology","Uveal Melanoma","Mitf","Cutaneous Melanoma"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"No poverty"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-26T16:14:42.235692Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}